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In response to the microenvironment, microglia may polarize into either an M1
pro-inflammatory phenotype, exacerbating neurotoxicity, or an M2 anti-inflammatory
phenotype, conferring neuroprotection. Betulinic acid (BA) is a naturally pentacyclic
triterpenoid with considerable anti-inflammatory properties. Here, we aim to investigate
the potential effects of BA on microglial phenotype polarization and to reveal the
underlying mechanisms of action. First, we confirmed that BA promoted M2 polarization
and inhibited M1 polarization in lipopolysaccharide (LPS)-stimulated BV-2 microglial
cells. Then, we demonstrated that the effect of BA on microglial polarization was
dependent on AMP-activated protein kinase (AMPK) activation, as evidenced by the
fact that both AMPK inhibitor compound C and AMPK siRNA abolished the M2
polarization promoted by BA. Moreover, we found that calmodulin-dependent protein
kinase kinase β (CaMKKβ), but not liver kinase B1, was the upstream kinase required
for BA-mediated AMPK activation and microglial M2 polarization, via the use of both
the CaMKKβ inhibitor STO-609 and CaMKKβ siRNA. Finally, BA enhanced AMPK
phosphorylation and promoted M2 microglial polarization in the cerebral cortex of LPS-
injected mice brains, which was attenuated by pre-administration of the AMPK inhibitor.
This study demonstrated that BA promoted M2 polarization of microglia, thus conferring
anti-neuroinflammatory effects via CaMKKβ-dependent AMPK activation.
Keywords: AMP-activated protein kinase, betulinic acid, calmodulin-dependent protein kinase β, microglia
polarization, neuroinflammation
Abbreviations: ACC, acetyl-CoA carboxylase; AMPK, AMP-activated protein kinase; Arg-1, arginase-1; BA, betulinic
acid; CaMKKβ, calmodulin-dependent protein kinase kinase β; CD16, cluster of differentiation 16; CD68, cluster of
differentiation 68; CD206, mannose receptor; CNS, central nervous system; COX-2, cyclooxygenase-2; IL-1β, interleukin-
1β; IL-6, interleukin-6; iNOS, inducible nitric oxide synthase; LKB1, liver kinase B1; LPS, lipopolysaccharide; MTT,
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide; NO, nitric oxide; PPAR-γ, peroxisome proliferator-activated
receptor-γ; ROS, reactive oxygen species; siRNA, small interfering RNA; TGFβ, transforming growth factor β; TNF-α, tumor
necrosis factor-α; Ym-1/2, chitinase 3-like 3.
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INTRODUCTION
Neuroinflammation is an inevitable and important pathological
process involved in all types of damages to, and disorders of, the
CNS (Ransohoff and Perry, 2009; Gemma, 2010; Dhama et al.,
2015). Accumulating evidence has established activated microglia
as major cellular elements of neuroinflammatory responses,
executing specific immune functions to maintain physiological
homoeostasis (Ransohoff and Perry, 2009; Gemma, 2010; Dhama
et al., 2015). In response to various microenvironmental
disturbances, microglia can be phenotypically polarized into
a classical (pro-inflammatory; M1) or an alternative (anti-
inflammatory; M2) phenotype (David and Kroner, 2011; Saijo
and Glass, 2011; Joseph and Venero, 2013; Mantovani et al.,
2013). Generally, activated M1 state microglia are characterized
by increased levels of pro-inflammatory cytokines, including
TNF-α, IL-1β, and IL-6, and the upregulation of iNOS,
CD16, and CD68, etc., whereas M2 phenotype microglia
have been shown to upregulate M2 phenotype markers, like
Arg-1, CD206, Ym-1/2, and TGFβ, etc. (David and Kroner,
2011; Saijo and Glass, 2011; Joseph and Venero, 2013;
Mantovani et al., 2013). Functionally, the M1 phenotype
exacerbates neuronal injury and impedes cellular repair after
CNS trauma and disorders. In contrast, the M2 microglia confers
neuroprotection and promotes recovery and remodeling (David
and Kroner, 2011; Saijo and Glass, 2011; Mantovani et al., 2013).
Therefore, the combination of inhibiting the M1 phenotype and
promoting the M2 stage is a potentially more viable strategy
than mere inhibition of the M1 activation for treatment of
neuroinflammatory disorders (Hu et al., 2015). However, there
are few compounds reported to regulate microglia polarization
toward the M2 phenotype (Lu et al., 2010; Zhou et al.,
2014).
Current evidence indicates that cellular energy metabolism
not only participates in inflammatory responses but also
regulates the conversion of functional phenotypes of microglia
(O’Neill and Hardie, 2013). The AMPK is an evolutionarily
conserved intracellular energy metabolism sensor that has
a central role in maintaining energy homeostasis (Amato
and Man, 2011; O’Neill and Hardie, 2013). The crystal
structure of AMPK has a catalytic α subunit, as well as
two regulatory (β and γ) subunits. It is well known that
AMPK activation is dependent on the phosphorylation of
α-subunit (Thr172 residue), which is mainly regulated by LKB1
or calcium/CaMKKβ in response to energy deprivation and
abnormal levels of intracellular Ca2+, respectively (Amato and
Man, 2011; O’Neill and Hardie, 2013). In fact, there are also
reports indicating that AMPK activators could significantly
inhibit M1 phenotypical inflammatory responses, thus protecting
against cellular and tissue damage (Sag et al., 2008; Bai et al.,
2010). Moreover, the activation of AMPK signal pathways
has been shown to promote macrophage/microglia polarization
toward the M2 stage, thus conferring anti-inflammatory effects
(Mounier et al., 2013; O’Neill and Hardie, 2013). On the other
hand, it has been demonstrated that the anti-inflammatory
properties of some widely known anti-inflammatory agents
are associated with the activation of the AMPK signaling
pathway (Lu et al., 2010; Lee and Kim, 2014; Mancuso
et al., 2014; Zhou et al., 2014; Hussein et al., 2015; Liu
et al., 2016; Velagapudi et al., 2017). Therefore, AMPK has
been considered as an attractive target for the treatment of
inflammatory disease (Amato and Man, 2011; O’Neill and
Hardie, 2013).
Betulinic acid [3β-hydroxy-lup-20(29)-en-28-oic acid] is a
naturally pentacyclic triterpenoid obtained from the outer bark
of several tree species, mainly white-barked birch trees (de
Melo et al., 2009). This compound has been reported to
possess various kinds of biological properties, including anti-
inflammatory, anticancer, antimalarial, and antiplatelet activities,
etc. (Lee et al., 2011; Wan et al., 2013; Jingbo et al., 2015;
Ju et al., 2015; Lingaraju et al., 2015; Kim et al., 2016;
Laavola et al., 2016). The anti-inflammatory effect of BA is
well recognized in several different models (Saaby and Nielsen,
2012; Wan et al., 2013; Ju et al., 2015; Lingaraju et al.,
2015; Kim et al., 2016; Laavola et al., 2016). First, BA could
inhibit LPS-stimulated release of inflammatory cytokines in
RAW 264.7 macrophages and protect against animal death
and tissue damage during LPS/polymicrobial-induced sepsis
(Lingaraju et al., 2015; Kim et al., 2016). Also, BA was found
to suppress inflammation via activation of PPAR-γ in human
osteoarthritis chondrocytes (Jingbo et al., 2015). In addition, BA
was reported to decrease LPS-induced matrix metalloproteinase-
9 expression via blocking the nuclear translocation of nuclear
factor-κB in microglial cells (Lee et al., 2011; Wan et al.,
2013). Recently, several reports also demonstrated that BA could
activate AMPK pathways in vitro and in vivo (Jin et al., 2016;
Silva et al., 2016; Xie et al., 2017). It is worth noting that BA-
induced CaMKKβ-dependent AMPK activation was reported
to confer protective actions in endothelial cells and in a non-
alcoholic fatty liver disease mouse model (Jin et al., 2016).
However, whether BA could promote microglial polarization
to M2 phenotype and whether AMPK activation is involved
in the anti-neuroinflammatory effects of BA have not been
investigated.
In the current study, we aimed to test the potential effects of
BA in microglia M2 polarization and to reveal the underlying
mechanisms of action. We found that BA induced AMPK
activation and promoted microglia polarization toward the M2
phenotype, thus inhibiting neuroinflammation. Furthermore,
we demonstrated that CaMKKβ-dependent AMPK activation is
required for BA-induced microglia M2 polarization.
MATERIALS AND METHODS
Chemicals
The BA (purity > 98%) and LPS (Escherichia coli serotype
055: B5) were supplied by J&K Scientific (Beijing, China)
and Sigma-Aldrich (St. Louis, MO, United States), respectively.
The compounds C, metformin, STO-609, and A769662 were
obtained from Selleck Chemicals (Shanghai, China). RPMI
1640, DMEM, OPTI medium, FBS, penicillin, streptomycin,
RNA iMAX Kit, DAPI solution, and BCA kit were purchased
from Thermo Fisher Scientific (Carlsbad, CA, United States).
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NO Colorimetric Assay Kit was purchased from BioVision
(Milpitas, CA, United States). The ELISA Ready-SET-Go Kits for
TNF-α and IL-10 were purchased from eBiosciences (San Diego,
CA, United States). High Pure RNA Isolation Kit, Transcriptor
First Strand cDNA Synthesis Kit, and FastStart Universal SYBR
Green Master Reagents were purchased from Roche Applied
Science (Mannheim, Germany). AMPKα, p-AMPK (Thr172),
LKB1, p-LKB1 (Ser428), p-CaMKKβ (Ser511), ACC, p-ACC
(Ser79), β-actin, GAPDH, and HRP-linked secondary antibody
were purchased from Cell Signaling Technology (Beverly, MA,
United States); iNOS, CaMKKβ, and Arg-1 were purchased
from Invitrogen (Carlsbad, CA, United States); CD68, CD206,
and YM1/2 were purchased from Abcam (Cambridge, MA,
United States).The donkey anti-goat, Alex Fluor 488, and donkey
anti-rabbit, Alex Fluor 647, secondary antibodies were obtained
from Jackson ImmunoResearch Laboratories (West Grove, PA,
United States). ECLplus Western Blotting Detection Reagents
Kit was purchased from GE Healthcare (NJ, United States).
All other chemicals and solvents were of molecular biology
grade.
Cell Culture
BV-2 cells, a widely used immortalized murine microglial cell
line, were obtained from Kunming Cell Bank of Type Culture
Collection, Kunming Institute of Zoology (Saleppico et al., 1996;
Wu et al., 2015). HeLa cells were purchased from the American
Type Culture Collection (Rockville, MD, United States). BV-2
cells and HeLa cells were cultured in RPMI 1640 and DMEM,
respectively. The medium was supplemented with 10% FBS,
100 U/mL penicillin, as well as 100 µg/mL streptomycin, in an
atmosphere of 95% air and 5% CO2 at 37◦C. Cells were then
passaged three times per week and used when the confluence
reached about 80%.
Cell Viability Assay and Morphological
Analysis
Cell viability was assessed by the MTT assay. Briefly, cells were
seeded in 24- or 96-well culture plates and received with indicated
treatments. After that, cells were incubated with MTT and finally
the absorbance at 570 nm was measured using a Flexstation
3 Microplate Reader (Molecular Devices, CA, United States).
For morphological analysis, cells were washed with pre-warmed
medium without phenol red, then observed, and imaged using
the Olympus IX73 microscope system (Olympus, Tokyo, Japan).
Experimental Animals and Protocols
Male C57BL/6 mice (25–30 g, about 8 weeks old) were obtained
from The Chinese University of Hong Kong. Animals were
maintained specific pathogen-free conditions with a 12 h
light/12 h dark cycle, under standard temperature and humidity,
and provided with regular daily diets and clean water ad
libitum. All animal experiments were performed according to
the National Institutes of Health Guide for the Care and Use of
Laboratory Animals with prior approval from the Institutional
Animal Ethical Committee (UMARE-007-2016 and UMARE-
AMEND-042).
The animals were randomly divided into four groups (n = 9):
vehicle group, LPS group, LPS+BA (30 mg/kg) group, and BA
(30 mg/kg) group. BA was initially dissolved in 5% (v/v) Tween
80 and then further suspended in normal saline. BA (30 mg/kg,
i.p.) was given once daily between 10:00 and 11:00 for 3 days.
The administration route and dose of BA were set based on
previous studies (Lingaraju et al., 2015). Treatment alone with
BA did not reduce food intake or any apparent toxicity in
animals. On day 4, the animals were injected intraperitoneally
with LPS (1 mg/kg) 1 h after the last drug administration (Henry
et al., 2008; Wu et al., 2015; Xu et al., 2015); 6 h after the
LPS stimulation, the animals were anesthetized and immediately
intracardially perfused with normal saline. Finally, the whole
brain was collected, and the cerebral cortex was separated for
additional experiments.
NO Assay
Microglial production of NO was assessed by measuring the
accumulated nitrite released into culture media. Briefly, BV-2
microglial cells were stimulated with LPS for 6 or 24 h. Then,
culture media were collected and analyzed via a NO Colorimetric
Assay Kit according to the manufacture’s protocol.
Enzyme-Linked Immunosorbent
Assay (ELISA)
The TNF-α and IL-10 release into conditioned media collected
from BV-2 microglia cells were assessed by ELISA Ready-SET-Go
Kits (eBiosciences, San Diego, CA, United States). The levels were
quantified following the manufacturer’s protocols.
Quantitative PCR (qPCR) Assay
Total RNA was extracted using the High Pure RNA Isolation
Kit according to the manufacturer’s protocol. Isolated RNA was
then reverse-transcribed into cDNA using the Transcriptor First
Strand cDNA Synthesis Kit following the standard protocol.
The qPCR assay was conducted using Fast Start Universal
SYBR Green Master Reagents with the Applied Biosystems 7900
HT Fast Real-Time PCR System (Applied Biosystems, Inc.,
Foster City, CA, United States). The amplification parameters
used here were 50◦C for 2 min then 95◦C for 10 min,
followed by 40 cycles of 95◦C for 15 s and 60◦C for 30 s.
Each sample was analyzed in triplicate, and the relative
expression of mRNA was calculated after normalization to
β-actin. All primer sequences used are listed in Supplementary
Table 1.
Small Interfering RNA (siRNA)
Transfection
At 24 h after plating, BV-2 cells with a confluence of 70–80% were
transfected with scrambled control siRNA, AMPKα siRNA, or
CaMKKβ siRNA (GenePharma, Shanghai, China). In brief, RNA
iMAX and siRNA were pre-mixed in OPTI medium according to
manufacturer’s protocols and then added into cultured cells; 24 or
36 h after transfections, OPTI medium was replaced by standard
DMEM medium with FBS for further experiments. All siRNA
sense strands used are listed in Supplementary Table 2.
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Western Blot Analysis
BV-2 cells and mouse brain cortex samples were lysed in
RIPA lysis buffer (Beyotime, Shanghai, China). Then, lysed
sample homogenates were centrifuged at 13,500 × rpm at
4◦C for 20 min. After centrifugation, the supernatants were
collected and the protein concentration was assessed by the BCA
kit. Aliquots of protein samples were resolved by SDS-PAGE
(7.5–15%) and transferred to PVDF membranes. Membranes
were blocked with 5% BSA, followed by incubation at
4◦C overnight with diluted primary antibodies. Membranes
were washed and incubated with HRP-anti-rabbit secondary
antibody for 1 h at room temperature. Finally, protein bands
were visualized using an ECLplus Western Blotting Detection
Reagents kit. Membranes were analyzed using a Bio-Rad
ChemiDoc XRS Imaging System with Quantity One Software
(version 4.5.2) (Bio-Rad, Hercules, CA, United States).
Immunohistochemistry
For BV-2 microglia staining, cells were washed, fixed,
permeabilized, and blocked. After that, cells were incubated
at 4◦C overnight with the primary antibodies. The next day,
cells were incubated secondary antibodies and DAPI. Finally, the
samples were imaged using the In Cell Analyzer 2000 system (GE
Healthcare).
For mouse brain staining, serial coronal cryosections (20 µm
thick) of cortex of each brain were prepared according
to the previous protocol. Briefly, after being fixed, washed,
permeabilized, and blocked, sections were incubated with
primary antibody. After that, sections were further incubated
with secondary antibody and DAPI solution. Sections were
imaged by a confocal microscope TCS SP5 (Lecia, Solms,
Germany). Cell numbers were calculated by counting of per
random microscopic field in a blinded fashion. Data are
expressed as the percentage of CD16/32+ or CD206+ cells to the
Iba-1+ cells.
Phagocytosis Assay
Phagocytic property was evaluated based on the uptake of
IgG FITC-conjugated latex beads (Phagocytosis Assay Kit;
Cayman Chemical, Ann Arbor, MI, United States) as per the
manufacturer’s protocol. Then, cells were observed and imaged
using the In Cell Analyzer 2000 system. The fluorescence
intensity of the cells was analyzed using Image J software and then
normalized to the untreated cells (National Institutes of Health,
United States).
Graphing and Statistical Analysis
Statistical analyses were performed using GraphPad Prism
software (version 6.0; GraphPad Software, Inc., San Diego, CA,
United States), and data are represented as means ± standard
error of the mean (SEM). Statistical analysis of differences
between two groups was done using the independent-samples’
t-test and one-way or two-way ANOVA with Bonferroni’s
correction applied was used for multiple group comparisons.
Pearson’s correlation coefficient was used for correlation analyses.
P< 0.05 was considered as statistically significant in all analyses.
RESULTS
BA Prevented LPS-Induced M1
Microglial Activation and Promoted
Microglial Polarization Toward the M2
Phenotype in BV-2 Microglial Cells
In order to estimate the range of effective concentrations, we
first measured the effects of BA, from 0.1 to 60 µM, on the cell
viability of BV-2 cells using the MTT assay. The results showed
that BA alone at concentrations lower than 10 µM did not cause
any detectable cytotoxicity in either BV-2 cells, with or without
LPS stimulation for up to 24 h (Figure 1, all p< 0.01 versus LPS-
treated group). Therefore, concentrations of 0.3, 1, 3, and 10 µM
were used in the following investigations.
In addition, the morphological changes of BV-2 following
treatment with BA or LPS were observed. As shown in Figure 1C,
the cells exhibited small soma with distal arborization, the
typical ramified morphology of resting microglia in the control
untreated group. BA (10 µM) alone treatment did not induce
any morphological changes of BV-2 cells. Following treatment
with LPS, the microglia became fewer and shorter branches
with a greatly enlarged cell body, the characteristic shapes of
activated microglia (Cheon et al., 2017). However, treatment with
BA attenuated the LPS-induced morphological changes in BV-2
microglia.
Then, we evaluated the role of BA in the LPS polarization
of BV-2 microglial cells. First, as illustrated in Figure 2,
LPS stimulation drastically induced M1 pro-inflammatory
polarization, as evidenced by the induction of the M1 pro-
inflammatory cytokine TNF-α (Figure 2A) and reduction of
the M2 anti-inflammatory cytokine IL-10 (Figure 2D) in BV-
2 microglial cells (all p < 0.01 versus the control group).
BA conferred little effect on microglia polarization in the
resting condition, while BA significantly suppressed LPS-induced
release of TNF-α (Figure 2A) in a dose-dependent fashion
(all p < 0.01 versus the LPS-treated group). Conversely,
BA increased IL-10 release in LPS-stimulated BV-2 microglial
cells in a dose-dependent manner (Figure 2D, all p < 0.001
versus the LPS-treated group). Furthermore, BA significantly
reduced mRNA expression of pro-inflammatory cytokines, such
as TNF-α, IL-6, and IL-1β (Figure 2B) and pro-inflammatory
mediators, like iNOS, CD16, and CD68 (Figure 2C), in LPS-
activated BV-2 microglial cells. Next, we found that the LPS-
induced decreased mRNA expression levels of M2 marker
genes, including IL-10, TGFβ1, CD206, Arg-1, and Ym1/2,
were also significantly increased by BA (10 µM) in BV-
2 microglia (Figures 2E,F, all p < 0.01 versus LPS-treated
group). Moreover, LPS stimulation decreased the expression
of CD206 at the protein level (Figure 2G), whereas BA
incubation prevented this tendency and increased the level of
CD206 to ∼15-fold that of the LPS-treated group in BV-2 (all
p < 0.01). In addition, BA decreased the protein expression
of iNOS to ∼0.5-fold that of the LPS-treated group in BV-
2 (Figure 2G, p < 0.01). To conclude, BA prevented LPS-
induced M1 microglial polarization and promoted the M2
phenotype.
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FIGURE 1 | Effects of betulinic acid (BA) on the cell viability and morphological change of BV-2 microglial cells, with or without lipopolysaccharide (LPS) stimulation.
BV-2 microglial cells were treated with BA with or without incubation of LPS (100 ng/mL) for 24 h. (A) Effects of BA alone on the cell viability. (B) Effects of BA on the
cell viability with LPS stimulation. (C) Effects of BA on morphological change, with or without LPS stimulation. Scale bar, 100 µm. Data are presented as
means ± SEM of three independent experiments in triplicate. Control group was untreated cells. #P < 0.01, versus control group; ∗P < 0.05 and ∗∗P < 0.01, versus
LPS-treated group.
BA Enhanced AMPK Phosphorylation in
BV-2 Microglial Cells
It is well known that AMPK activation is dependent on
the phosphorylation of Thr172 in the protein loop (Amato
and Man, 2011; O’Neill and Hardie, 2013). Of note, in LPS
stimulation-free BV-2 cells, BA (10 µM) significantly elevated
AMPK phosphorylation; the elevation was found at 0.5 h,
peaked at about 2 h, and lasted for more than 8 h, after BA
treatment (Figure 3A, p < 0.01 versus control group). Previous
reports indicated that LPS-stimulated macrophages displayed
a reduced AMPK activation (Sag et al., 2008). Consistently,
we found that LPS markedly decreased the phosphorylation
of AMPK in microglia after LPS stimulation (Figure 3B,
p < 0.01 versus control group). However, BA treatment
reversed the LPS-inhibited AMPK phosphorylation (Figure 3B,
all p< 0.01 versus control group). More relevantly, BA-enhanced
AMPK and ACC phosphorylation was remarkably weakened
by compound C, a well-established AMPK inhibitor, in BV-2
cells (Figure 3B). To further verify that BA enhanced AMPK
activity, we tested the role of BA in the phosphorylation (Ser-
79) of ACC, a well-established substrate of activated AMPK.
BA significantly increased levels of phosphorylated ACC in
BV-2 cells (Figure 3C), which clearly indicated enhancing
effects of BA on AMPK activity. In conclusion, we found
that BA could promote AMPK phosphorylation in microglial
cells.
AMPK Activation Was Required for
BA-Mediated M2 Microglial Polarization
in BV-2 Microglial Cells
To investigate the role of BA-induced AMPK activation in
microglial polarization, we then tested whether AMPK inhibition
by pharmacological inhibition or AMPK-specific siRNA could
block the M2 microglial polarization caused by BA. First, BA-
induced inhibition of TNF-α expression, and gene expression
of TNF-α, IL-6, IL-1β, iNOS, CD16, and CD68 were in part
attenuated by the AMPK inhibitor, compound C, in BV-2
cells (Figures 4A–C, all p < 0.01 versus the LPS-treated
group). Moreover, compound C entirely abolished BA-mediated
upregulation of IL-10, TGFβ1, CD206, Arg, and Ym1/2 in LPS-
treated BV-2 (Figures 4E,F, all p < 0.01 versus the BA and LPS-
treated group). In addition, compound C decreased IL-10 protein
expression levels, and antagonized the enhanced expression by
BA treatment in BV-2 cells (Figure 4D, p < 0.01 versus the BA
and LPS-treated group). Then, the AMPK siRNA was used to
knockout AMPK in BV-2 microglial cells; as expected, AMPK
protein expression was significantly decreased at 24 and 36 h after
transfection (Figure 5A). Therefore, 24 h after transfection was
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FIGURE 2 | BA prevented LPS-induced M1 microglia activation and promoted microglia polarization to the M2 phenotype in BV-2 microglial cells. Cells were treated
with BA for 1 h, followed by LPS stimulation for 6 or 24 h. The cytokine level was determined by ELISA. The mRNA expression level was determined by qPCR assay.
(A) BA inhibited LPS-induced TNF-α release into the culture media of BV-2 cells. (B,C) BA inhibited LPS-induced mRNA expression TNF-α, IL-1β, IL-6, iNOS, CD16,
and CD68. (D) BA enhanced IL-10 release into culture media. (E,F) BA prevented the LPS-induced downregulation of TGFβ1, IL-10, CD206, Arg-1, and
YM1/2expression. (G,H) BA significantly decreased the iNOS expression, whereas increased the CD206 expression in BV-2 cells, evidenced by Western blot assay
and immunofluorescence staining. Scale bar, 25 µm. Data are presented as means ± SEM of three independent experiments in triplicate. Control group was
untreated cells. #P < 0.01, versus control group; ∗P < 0.05 and ∗∗P < 0.01, versus LPS-treated group.
selected in this study. AMPK knockdown partially abolished BA-
mediated inhibition of LPS-induced production of TNF-α, as well
as iNOS mRNA level (Figures 5B,C, both p< 0.01 versus control
siRNA group). Consistent with the results obtained using the
AMPK inhibitor, AMPK knockdown by siRNA totally reversed
BA-enhanced IL-10 release and expression of CD206 and Arg-
1, indicating that the BA-induced M2 microglial polarization
was significantly suppressed by AMPK gene silence in BV-2
microglial cells (Figures 5D–F, all p < 0.01 versus the control
siRNA group). Collectively, we showed that BA-promoting effects
on M2 phenotype polarization were due in part to BA-induced
AMPK activation in microglial cells.
CaMKKβ Was the Upstream Kinase
Involved in BA-Induced AMPK Activation
in BV-2 Microglial Cells
AMP-activated protein kinase is mainly activated by two
major upstream kinases, CaMKKβ and LKB1, in response to
energy deprivation and abnormal levels of intracellular Ca2+,
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FIGURE 3 | BA enhanced AMPK activation in BV-2 microglial cells. Cells were pretreated with or without AMPK inhibitor compound C (CC) for 0.5 h and then treated
with BA alone or BA and LPS. (A) BA increased AMPK phosphorylation in BV-2 cells without LPS stimulation. (B,C) The AMPK inhibitor CC inhibited BA-enhanced
AMPK and ACC phosphorylation. Data are presented as means ± SEM of three independent experiments in triplicate. Control group was untreated cells. #P < 0.01,
versus control group; ∗P < 0.05 and ∗∗P < 0.01, versus LPS-treated group. Two columns sharing the same letter are significantly different (P < 0.05).
respectively (Amato and Man, 2011; O’Neill and Hardie, 2013).
To identify which kinase was required for BA-induced AMPK
activation, we first tested the effects of BA on the phosphorylation
of CaMKKβ and LKB1. BA (10 µM) significantly activated
CaMKKβ (Figure 6A), but not LKB1 (Figure 6B) in BV-
2 microglia cells (all p < 0.01 versus control group). Next,
we tested the effects of BA on AMPK phosphorylation in
a well-established LKB1-deficient cell line, HeLa cells. HeLa
cells show a lack of LKB1 expression. However, as shown in
Figure 6C, BA still promoted remarkable AMPK activation in
HeLa cells (all p< 0.01 versus control group), indicating that BA-
activated AMPK was independent of LKB1. Next, we investigated
whether CaMKKβ was required for BA activation of AMPK.
We observed that BA-activated AMPK phosphorylation was
significantly attenuated by the CaMKKβ inhibitor STO-609 in
LPS-treated BV-2 microglial cells (Figure 6D). Collectively, by
using both pharmacological and siRNA approaches, we showed
that BA activated microglial AMPK in a CaMKKβ-dependent
manner.
BA Promoted Microglia M2 Polarization
via CaMKKβ-Dependent AMPK
Activation
We further investigated whether CaMKKβ was functionally
required for BA’s promoting effects on M2 microglial
polarization. First, BA-induced inhibition of TNF-α expression,
and gene expression of TNF-α, IL-6, IL-1β, iNOS, CD16,
and CD68 were in part attenuated by the CaMKKβ inhibitor,
STO-609 in BV-2 cells (Figures 7A–C, all p < 0.01 versus the
LPS-treated group). Moreover, STO-609 entirely abolished IL-10
protein expression, which was enhanced by BA treatment in
BV-2 cells (Figure 7D, p < 0.01 versus BA and LPS-treated
group). In addition, STO-609 entirely abolished BA-induced
upregulation of IL-10, TGFβ1, CD206, Arg, and Ym1/2 in
LPS-treated BV-2 (Figures 7E,F, all p < 0.01 versus BA and
LPS-treated group). Consistently, CaMKKβ siRNA also displayed
similar effects on the expression of IL-10, CD206, and Arg-1
in BV-2 cells (Figures 8A,D–F), indicating that CaMKKβ
knockdown also abolished the effects of BA on promoting
microglia toward M2 polarization. On the other hand, even
though CaMKKβ knockdown decreased BA-mediated inhibition
of LPS-induced microglia M1 inflammation (upregulation
of TNF-α and iNOS, as shown in Figures 8A–C), CaMKKβ
siRNA did not completely abolish BA’s inhibitory effects on M1
inflammation. In conclusion, M2 polarization by BA involves
CaMKKβ-dependent AMPK activation.
BA Induced CaMKKβ/AMPK
Phosphorylation and Promoted Microglia
M2 Polarization in the LPS-Induced
Mouse Model
It is well known that LPS triggers robust immune responses
and intraperitoneal injection of LPS is widely used to induce
systemic inflammation and behavior responses in rodent models
(Henry et al., 2008; Xu et al., 2015). As shown in Figures 9A,B,
compared with the control and LPS group, treatment with BA
(30 mg/kg) significantly increased phosphorylation of CaMKKβ
and AMPK in the cerebral cortex. LPS injection significantly
induced the expression of TNF-α and iNOS in mRNA and
reduced CD206 and Arg-1 mRNA expression (Figures 9C,D,
all p < 0.01 versus vehicle group). Conversely, BA (30 mg/kg)
administration suppressed LPS-induced mRNA expression of
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FIGURE 4 | AMPK activation is involved in BA-mediated microglial M2 microglia polarization in BV-2 microglial cells. BV-2 cells were pretreated with AMPK inhibitor
compound C (CC) for 0.5 h, and then with BA for another 1 h, followed by exposure to LPS stimulation for 6 or 24 h. (A) AMPK inhibitor attenuated BA inhibition of
LPS-induced TNF-α production. (B,C) The AMPK inhibitor reversed BA inhibition of LPS-induced mRNA expression of TNF-α, IL-1β, IL-6, iNOS, CD16, and CD68.
(D) The AMPK inhibitor abolished BA-enhanced IL-10 release into culture media. (E,F) The AMPK inhibitor abolished BA-enhanced mRNA expression of TGFβ1,
IL-10, CD206, Arg-1, and YM1/2. Data are presented as means ± SEM of three independent experiments in triplicate. Control group was untreated cells. #P < 0.01,
versus control group; ∗P < 0.05 and ∗∗P < 0.01, versus LPS-treated group. Two columns sharing the same letter are significantly different (P < 0.05).
TNF-α and iNOS, and promoted enhanced M2 gene CD206 and
Arg-1 mRNA expression (all p< 0.01 versus BA and LPS-treated
group).
The morphology of microglia cells in the resting condition
most frequently showed a small and ovoid shape. Most of
the LPS-stimulated microglia cells had morphology changes
with large and flat shape, while BA can inhibit activation of
the microglia by LPS, as evidenced by typically resembling
morphology that was seen in the control group (Figures 9E,F).
The expression of the M1 marker CD16/32 was lower in
Iba1+ microglia in LPS + BA treated group than that
in LPS group (Figures 9E,G). Moreover, the co-expression
levels of the M2 marker CD206 and Iba1 were higher
in the LPS + BA group compared with the LPS group
(Figures 9E,H).
BA Had No Effect on Phagocytic
Capacity in LPS-Activated BV-2
Microglial Cells
The phagocytic ability of microglia following treatment with
LPS with or without BA was comparatively examined through
quantification of their capacity to phagocytose IgG FITC-
conjugated latex beads. As shown in Figure 10, compared to
control untreated cells, LPS stimulation of BV2 microglia to an
M1 phenotype enhanced their ability to phagocytose fluorescent
beads (p < 0.01). Interestingly, we observed that BA treatment
did not impair LPS-enhanced phagocytic capacity in BV-2 cells
(p< 0.01 versus LPS-treated group).
DISCUSSION
Inflammatory responses are inevitable and important
pathological processes in several kinds of neurological
diseases (Ransohoff and Perry, 2009). Microglia-mediated
neuroinflammation and subsequent neurological damage
contribute to several neurodegenerative diseases, like multiple
sclerosis (MS), Alzheimer’s disease, and Parkinson’s disease
(Ransohoff and Perry, 2009; Gemma, 2010; Dhama et al., 2015).
Similar to macrophages, microglial cells show plasticity, and
can polarize into different functional phenotypes in response to
various microenvironmental disturbances. There are two two
extremes: the pro-inflammatory M1 phenotype that induces
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FIGURE 5 | Knockdown of AMPK by siRNA attenuated BA-mediated microglia polarization in BV-2 microglial cells. Cells were first transfected with 40 nM AMPKα
siRNA for 24 h, and then treated with BA for 1 h, followed by exposure to LPS stimulation for 6 or 24 h. (A) Transfection for 24 h was able to decrease the
expression of AMPKα protein. (B,C) AMPKα knockdown decreased BA-mediated inhibition of TNF-α production, and mRNA expression of TNF-α and iNOS in
LPS-stimulated BV-2 cells. (D–F) AMPKα knockdown attenuated BA-enhanced IL-10 release and mRNA expression of CD206 and Arg-1. Data are presented as
means ± SEM of three independent experiments in triplicate. Control group was that treated with control siRNA but not BA or LPS. Two columns sharing the same
letter are significantly different (P < 0.05).
pro-inflammatory cytokine release and exacerbates neuronal
disorders, and the anti-inflammatory M2 phenotype that confers
neuroprotective effects via enhancing the expression of genes
involved in inflammation resolution, immunomodulation,
homeostasis, scavenging, angiogenesis, and wound healing
(David and Kroner, 2011; Saijo and Glass, 2011; Joseph and
Venero, 2013; Mantovani et al., 2013). The pro- and anti-
inflammatory responses need to be balanced to prevent the
potential detrimental effects of a prolonged, unregulated
inflammation. Thus far, the evidence presented for inflammation
in neurodegenerative diseases points to an uncontrolled and
prolonged M1-activated state that contributes to additional
neuronal damage (David and Kroner, 2011; Saijo and Glass,
2011; Joseph and Venero, 2013; Mantovani et al., 2013).
However, simply inhibiting inflammation by suppressing M1
activation would likely not confer overall benefits based on
previous non-steroidal anti-inflammatory drug and AD anti-
inflammatory prevention trial studies (Becker et al., 2011; Hu
et al., 2015). Microglia activation states in neurodegeneration
may need to be specifically treated by simultaneously attenuating
M1 responses and promoting M2 responses. Inhibiting the
M1 phenotype while stimulating the M2 phenotype has been
suggested as a more viable potential strategy for the treatment
of neuroinflammatory disorders (Hu et al., 2015). For instance,
two agents approved for MS therapy, glatiramer acetate and
β-interferon, have demonstrated not only M1-inhibiting actions,
but also promote a balance between M1 and M2 cells (Burger
et al., 2009; Kieseier, 2011). However, most of the compounds
reducing neuroinflammation simply suppress M1 phenotype
microglia, and few compounds have been demonstrated to
promote the polarization of microglia to the M2 phenotype
(Burger et al., 2009; Kieseier, 2011; Huang et al., 2017). BA
is a widely used natural product and its anti-inflammatory
properties are well known (Saaby and Nielsen, 2012; Wan
et al., 2013; Ju et al., 2015; Lingaraju et al., 2015; Kim et al.,
2016; Laavola et al., 2016). Moreover, BA was able to decrease
pro-inflammatory cytokine release and matrix metalloproteinase
expression in LPS-stimulated microglial cells, indicating a
definite anti-neuroinflammatory role of BA in CNS (Lee et al.,
2011; Wan et al., 2013). Therefore, it is of significance to test
the role of BA in the regulation of microglia polarization,
and to further explore the possible molecular mechanisms.
Generally, in activated microglia, M1 or M2 polarization is
characterized and distinguished by expression of pro- and
anti-inflammatory genes and proteins, respectively (David and
Kroner, 2011; Saijo and Glass, 2011; Joseph and Venero, 2013;
Mantovani et al., 2013). LPS is a classical Toll-like-receptor-4
agonist that can not only polarize microglia into the M1 pro-
inflammatory phenotype, thus inducing inflammatory responses,
but also decrease the expression of M2 anti-inflammatory
markers, thus attenuating inflammation (David and Kroner,
2011; Saijo and Glass, 2011; Joseph and Venero, 2013;
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FIGURE 6 | BA activated AMPK in a CaMKKβ-dependent manner in BV-2 microglia cells. Cells were pretreated with or without CaMKKβ inhibitor STO-609 (STO) for
0.5 h and then treated with BA alone or BA and LPS. (A) BA time-dependently increased CaMKKβ phosphorylation in BV-2 cells. (B) BA had no effect on LKB1
phosphorylation in BV-2 cells. (C) BA was able to increase the level of AMPK phosphorylation in HeLa cells. (D) STO attenuated BA-induced AMPK activation in
BV-2 microglia. Data are presented as means ± SEM of three independent experiments in triplicate. Control group was untreated cells. #P < 0.01, versus control
group; ∗P < 0.05 and ∗∗P < 0.01, versus LPS-treated group. Two columns sharing the same letter are significantly different (P < 0.05).
Mantovani et al., 2013). Therefore, the LPS-stimulated microglial
models were widely used to explore the regulation and
mechanism of microglial polarization (Henry et al., 2008; Xu
et al., 2015). First, we confirmed that BA treatment could
inhibit LPS-induced morphological changes of activated
microglia in BV-2 cells. The current data also indicated that
BA could significantly promote microglial polarization toward
the anti-inflammatory M2 phenotype in LPS-stimulated BV-2
microglial cells. Recent studies have indicated the importance
of the phagocytic activity of microglia in the injured CNS,
in which the phagocytosis of dead neurons is crucial for
recovery and promotes axon regeneration and restoration of
the microenvironment (Cheon et al., 2017; Paetau et al., 2017).
Previous study reported a phenomenon that the important
role of classically activated M1 microglia, phagocytosis and
debris clearance, was retained in the converted M2 phenotype
microglia (Cheon et al., 2017; Paetau et al., 2017). Interestingly,
in the current study, we also found that BA did not impair the
phagocytic activity of activated microglia. Furthermore, the
cellular results were confirmed by the results of the systemic LPS
injection mouse model. The in vivo data also indicated that BA
remarkably suppressed M1 phenotype marker expression and
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FIGURE 7 | CaMKKβ-dependent AMPK activation is involved in BA-mediated microglia polarization in BV-2 microglial cells. BV-2 cells were pretreated with CaMKKβ
inhibitor STO-609 (STO) for 0.5 h, and then with BA for another 1 h, followed by exposure to LPS stimulation for 6 or 24 h. (A) STO reversed BA inhibition of
LPS-induced TNF-α production. (B,C) STO attenuated BA inhibition of LPS-induced mRNA expression of TNF-α, IL-1β, IL-6, iNOS, CD16, and CD68. (D) STO
abolished BA-enhanced M2 marker protein IL-10 release into culture media. (E,F) STO abolished BA-enhanced mRNA expression of TGFβ1, IL-10, CD206, Arg-1,
and YM1/2. Data are presented as means ± SEM of three independent experiments in triplicate. Control group was untreated cells. #P < 0.01, versus control group;
∗P < 0.05 and ∗∗P < 0.01, versus LPS-treated group. Two columns sharing the same letter are significantly different (P < 0.05).
promoted polarization of microglial cells into the M2 phenotype,
which might contribute to BA-induced neuroprotective effects on
neuroinflammation. Taken together, the current data suggested
that BA could promote microglia polarization toward the M2
anti-inflammatory phenotype, which at least in part contributes
to BA-mediated neuroprotection.
Accumulating evidence indicates that cellular energy
metabolism not only participates in inflammatory responses
but also regulates the conversion of functional phenotypes in
immune cells (O’Neill and Hardie, 2013). The AMPK is an
evolutionarily conserved intracellular energy metabolism sensor
that has a central role in maintaining energy homoeostasis
(Amato and Man, 2011; O’Neill and Hardie, 2013). AMPK
is one of the most important endogenous neuroprotective
molecules against inflammatory responses (Sag et al., 2008;
Bai et al., 2010). AMPK not only plays a crucial role in
suppressing inflammatory cytokines and mediators in activated
microglia, but also promotes microglial polarization toward
the M2 stage (Amato and Man, 2011; O’Neill and Hardie,
2013; Hussein et al., 2015; Liu et al., 2016; Velagapudi et al.,
2017). Therefore, AMPK has been considered as an attractive
target for the treatment of inflammatory diseases (Amato
and Man, 2011; O’Neill and Hardie, 2013). Recently, several
reports also demonstrated that BA could activate AMPK
pathways in various in vitro and in vivo models (Jin et al.,
2016; Silva et al., 2016; Xie et al., 2017). On the other hand,
accumulating data indicated that the anti-inflammatory
properties of some widely known anti-inflammatory agents,
like salicylate, are also strongly associated with the activation of
the AMPK signaling pathway (Hawley et al., 2012). Moreover,
some synthetic and natural compounds that could induce
AMPK also confer anti-inflammatory actions and promote
M2 polarization of microglia (Lu et al., 2010; Lee and Kim,
2014; Mancuso et al., 2014; Zhou et al., 2014). Hence, it
was of interest to investigate the relationship between anti-
neuroinflammatory effects and AMPK activation by BA.
In the current study, we first found that, in the absence of
LPS, BA robustly increased AMPK phosphorylation in BV-2
microglial cells. LPS, usually served as a potent M1 inducer,
was also observed to significantly decrease AMPK activity
in microglia cells. However, BA not only attenuated LPS-
induced AMPK activation reduction but also raised AMPK
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FIGURE 8 | Knockdown of CaMKKβ by siRNA attenuated BA-promoting effects on M2 polarization of BV-2 microglial cells. Cells were first transfected with 45 nM
CaMKKβ siRNA for 24 h, and then treated with BA for 1 h, followed by exposure to LPS stimulation for 6 or 24 h. (A) Transfection for 24 h was able to decrease the
expression of CaMKKβ protein. (B,C) CaMKKβ knockdown decreased BA-mediated inhibition of TNF-α production, and mRNA expression of TNF-α and iNOS in
LPS-stimulated BV-2 cells. (D–F) CaMKKβ knockdown abolished BA-enhanced IL-10 release and mRNA expression CD206 and Arg-1. Data are presented as
means ± SEM of three independent experiments in triplicate. Control group was that treated with control siRNA but not BA or LPS. Two columns sharing the same
letter are significantly different (P < 0.05).
phosphorylation up to the level several-folds that of the
baseline. These current data are consistent with previous
reports showing that BA-induced AMPK activation conferred
protection in endothelial cells and mouse models (Lingaraju
et al., 2015; Jin et al., 2016). Next, we confirmed that BA’s
effects on inhibiting M1 polarization and promoting M2
polarization were dependent on AMPK activation using the
AMPK inhibitor, compound C, and AMPKα siRNA to block
AMPK. Of note, pre-treatment with an AMPK inhibitor
or AMPKα siRNA abolished BA-mediated regulation of M2
markers in LPS-stimulated BV-2 cells. The current data also
coincided with a previous publication, indicating that increased
number of M2 microglia subtype population may enhance
AMPK activity as a feedback mechanism (Sag et al., 2008).
In addition, BA-enhanced AMPK phosphorylation was also
found in the cerebral cortex in an LPS-stimulated mouse
model. Based on the above-mentioned results, we suggested
that BA’s beneficial effects in the mouse model might be, at
least in part, mediated by AMPK activation. Therefore, the
current results suggested that BA-promoted microglia M2
polarization was mediated by the activation of AMPK signaling
pathways.
It is well known that AMPK activation is dependent on
the phosphorylation of Thr172 in the activated loop (Amato
and Man, 2011; O’Neill and Hardie, 2013). AMPK can be
activated by multiple mechanisms (Mounier et al., 2013;
O’Neill and Hardie, 2013). For instance, AMPK activation
could be regulated by its major upstream AMPK kinase,
LKB1, in response to energy fluctuations (Amato and Man,
2011; O’Neill and Hardie, 2013). Correspondently, certain
AMPK activators, like metformin, act through respiratory
chain inhibition and indirectly activate AMPK; furthermore,
LKB1 is indispensable for metformin-induced activation of
AMPK (Owen et al., 2000). In addition to LKB1, CaMKKβ
is another upstream kinase that can directly phosphorylate
AMPK on Thr172 in response to changes in intracellular
calcium (Amato and Man, 2011; O’Neill and Hardie, 2013).
Therefore, further experiments were designed to investigate
the role of BA in these two upstream kinases (Kieseier,
2011; Hawley et al., 2012). First, we found that BA induced
CaMKKβ phosphorylation, but not of LKB1, in BV-2 microglial
cells. Next, we found that AMPK was also phosphorylated
in LKB1-deficient HeLa cells (Racioppi et al., 2012), which
further suggested that BA-mediated AMPK activation was
not dependent on LKB1 activity. On the other hand, the
application of the pharmacological CaMKKβ inhibitor, STO-609,
significantly abolished BA-induced AMPK phosphorylation,
all of which indicated that CaMKKβ is indispensable for BA-
mediated AMPK activation. The role of BA in regulating
CaMKKβ-dependent activation of AMPK in microglial
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FIGURE 9 | Effects of BA on CaMKKβ/AMPK activation and microglia M2 polarization in the LPS-induced mouse model. The animals were treated with or without
BA (30 mg/kg, i.p., once per day) for 4 days, and then injected intraperitoneally with LPS (1 mg/kg) 1 h after the last BA treatment; 6 h after LPS stimulation, animals
(Continued)
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FIGURE 9 | Continued
were sacrificed and brains were then obtained and further isolated for assay. (A) BA significantly increased the phosphorylation of CaMKKβ and AMPK in the
cerebral cortex of mouse brain. (B) BA obviously inhibited iNOS expression, but enhanced M2 marker protein CD206 expression. (C,D) BA significantly inhibited the
mRNA expression of TNF-α and iNOS, whereas it increased mRNA expression of CD206 and Arg-1. (E,F) Double staining of Iba1 (green) with CD16/32 (red) or
CD206 (red) in slices section of cerebral cortex. Nuclei are counterstained with DAPI (blue). Scale bar, 20 µm. Arrows indicate obvious CD16/32 or CD206 positive
microglia. Representative images were obtained from one set of experiments, and the three experiments were performed independently. (G,H) The quantity of the
percentage of CD16/32+ to Iba1+ cells and CD206 to Iba1+ cells. Data are presented as means ± SEM. Control group was untreated cells. ∗P < 0.05 and
∗∗P < 0.01, versus LPS-treated group.
FIGURE 10 | BA had no effect on phagocytic capacity in LPS-activated BV-2 microglial cells. BV-2 cells were treated with BA for 1 h and then incubated with LPS
for another 24 h. (A) Effect of BA on phagocytic capacity in LPS-activated BV-2 cells. Scale bar, 20 µm. (B) The relative fluorescence intensity of the cells. Data are
presented as means ± SEM of three independent experiments in triplicate. Control group was untreated cells. #P < 0.01, versus control group.
cells was consistent with previous reports showing that BA
could induce CaMKKβ-dependent, but not LKB1-dependent
AMPK activation in endothelial cells and in a mouse model
of non-alcoholic fatty liver disease. Although the detailed
mechanisms of CaMKKβ’s action in microglia-mediated
inflammation still remain unclear, it appears that CaMKKβ
confers anti-inflammatory effects in microglial cells in
several models (Racioppi et al., 2012). There were several
reports indicating that some agents, including berberine,
telmisartan, and H2S donors, induce CaMKKβ-dependent
AMPK activation and promote M2 polarization of microglia
via the CaMKKβ/AMPK pathway (Lu et al., 2010; Zhou
et al., 2014; Xu et al., 2015). Based on the current results,
we suggest that BA promoted M2 polarization of microglia
via CaMKKβ-dependent AMPK activation in microglia cells.
However, further studies are warranted to determine whether BA
directly activates CaMKKβ or indirectly regulates CaMKKβ via
other targets.
In the current study, we also found BA to be a potent
AMPK activator. Activation of the AMPK signaling pathway has
considerable therapeutic potential in several neuroinflammation-
associated diseases (Russo et al., 2013). Therefore, BA could be
further exploited as a novel agent for treating these disorders.
Moreover, most of the drugs targeting AMPK activation in
current clinical use act mainly via mitochondrial inhibition,
increasing AMP/ATP ratios during AMPK activation (Cunniff
et al., 2016; Xu and Ash, 2016). In contrast, no agents have been
shown to directly mediate AMPK activation or indirectly regulate
upstream kinases, other than LKB1, in human studies (Cunniff
et al., 2016; Xu and Ash, 2016). Our results interestingly showed
that BA-mediated AMPK activation was dependent on CaMKKβ,
but not LKB1, in microglial cells. Whether BA-induced activation
of AMPK is also dependent on an increase in the AMP/ATP
ratio, or whether CaMKKβ activation alone for the activation
of AMPK by BA, will be investigated in our future studies.
Furthermore, AMPK is an upstream kinase that regulates PPARγ
activation, indicating that the relationship between these two
systems is context-dependent (Yazawa et al., 2010; He et al., 2011).
It is well-estbalished that AMPK and peroxisome PPARγ are
closely integrated in microglia cells, showing similar effects such
as inhibiting pro-inflammatory gene expression and regulating
energy metabolism balance (Yazawa et al., 2010; He et al.,
2011). Previous reports also demonstrated that BA inhibited IL-
1β-induced inflammation via activating PPARγ in osteoarthritis
chondrocytes. Therefore, it is also interesting to further explore
the role of BA in regulating the PPARγ pathway in microglia cells.
CONCLUSION
Our study demonstrated that BA promoted microglia
polarization toward the M2 phenotype via CaMKKβ-dependent
AMPK activation. Therefore, the current results supported the
notion that BA treatment could confer anti-neuroinflammatory
actions and might have considerable value as a therapeutic agent
against neuroinflammatory diseases.
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